Cracking the estrogen receptor's posttranslational code in breast tumors

Area of Science:

• Oncology
• Molecular Biology
• Endocrinology

Background:

• Estrogen signaling pathways are key targets in breast cancer therapy.
• Estrogen receptors (ER) play a critical role in breast tumorigenesis.
• Resistance to endocrine therapy remains a significant clinical challenge.

Purpose of the Study:

• To provide an overview of estrogen receptor (ER) post-translational modifications (PTM).
• To focus on the deregulation of ER PTM in breast cancer.
• To discuss the clinical relevance and functional relationships of ER PTM.

Main Methods:

• Literature review of current and emerging knowledge on ER PTM.
• Analysis of the role of various PTMs (acetylation, ubiquitination, etc.) in ER function.
• Discussion of the impact of PTMs on breast carcinogenesis and endocrine therapy.

Main Results:

• Estrogen receptor (ER) function is modulated by various post-translational modifications (PTM) beyond phosphorylation.
• These PTMs influence ER expression, stability, localization, and hormonal response.
• Deregulation of ER PTM is implicated in breast cancer initiation and progression.

Conclusions:

• Understanding ER PTM is essential for comprehending breast cancer development.
• ER PTMs represent potential biomarkers for prognosis and predicting response to endocrine therapy.
• Targeting ER PTMs may lead to novel therapeutic strategies for breast cancer.